Related Experiment Video
Updated: Jul 7, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
p73 poses a barrier to malignant transformation by limiting anchorage-independent growth
Michaela Beitzinger1, Lars Hofmann, Claudia Oswald
1Molecular Tumor Biology Group, Rudolf-Virchow-Center, University of Würzburg, Würzburg, Germany.
Abstract:
p53 is known to prevent tumour formation by restricting the proliferation of damaged or oncogene-expressing cells. In contrast, how the p53 family member p73 suppresses tumour formation remains elusive. Using a step-wise transformation protocol for human cells, we show that, in premalignant stages, expression of the transactivation-competent p73 isoform TAp73 is triggered in response to pRB pathway alterations. TAp73 expression at this stage of transformation results in increased sensitivity to chemotherapeutic drugs and oxidative stress and inhibits proliferation and survival at high cell density. Importantly, TAp73 triggers a transcriptional programme to prevent anchorage-independent growth, which is considered a crucial hallmark of fully transformed cells. An essential suppressor of anchorage-independent growth is KCNK1, which is directly transactivated by TAp73 and commonly downregulated in glioma, melanoma and ovarian cancer. Oncogenic Ras switches p73 expression from TAp73 to the oncogenic deltaNp73 isoform in a phosphatidyl-inositol 3-kinase-dependent manner. Our results implicate TAp73 as a barrier to anchorage-independent growth and indicate that downregulation of TAp73 is a key transforming activity of oncogenic Ras mutants.
Insights
The p73 protein isoform TAp73 acts as a tumor suppressor by preventing anchorage-independent growth. Oncogenic Ras proteins reduce TAp73 levels, promoting cancer development.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- The tumor suppressor protein p53 prevents cancer by controlling damaged cells.
- The function of the p53 family member p73 in tumor suppression is not well understood.
Purpose of the Study:
- To investigate the role of p73 in preventing tumor formation during premalignant stages.
- To identify the mechanisms by which p73 suppresses cancer hallmarks.
Main Methods:
- Utilized a step-wise transformation protocol in human cells.
- Analyzed gene expression changes in response to pRB pathway alterations.
- Investigated the transcriptional targets of TAp73, including KCNK1.
- Examined the effect of oncogenic Ras on p73 isoform expression via phosphatidyl-inositol 3-kinase signaling.
Main Results:
- TAp73 expression is induced during premalignant stages due to pRB pathway alterations.
- TAp73 increases sensitivity to chemotherapy and oxidative stress, inhibiting proliferation and survival.
- TAp73 activates KCNK1, a suppressor of anchorage-independent growth, which is downregulated in several cancers.
- Oncogenic Ras shifts p73 expression from TAp73 to deltaNp73 in a PI3K-dependent manner.
Conclusions:
- TAp73 functions as a critical barrier against anchorage-independent growth, a key cancer hallmark.
- Downregulation of TAp73 by oncogenic Ras is a significant mechanism in tumor transformation.
- TAp73 and its target KCNK1 represent potential therapeutic targets for cancers with altered p73 signaling.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle
